[en] Objectives : To evaluate the impact of NSAID use on current routine upper GI endoscopy (UGIE) and to compare the lesions found in NSAID users and non-users. Methods : Participating gastroenterologists; consecutively documented outpatients with and without suspicion of bleeding, referred for upper gastrointestinal endoscopy. Patient characteristics, presence of risk factors, NSAID use and endoscopic findings were reported on standard data collection forms. Main results : A total of 2685 non-bleeding and 159 bleeding patients were enrolled within a time period of 2 months. NSAID therapy was present in 20% of the non-bleeding patients and at least 9% of referrals for endoscopy were directly related to suspected NSAID adverse events. Nearly half of acute bleeding patients (42%) were NSAID users, including aspirin for cardioprevention. Warning digestive symptoms prior to acute bleeding were frequently absent (56%). Oesophagitis was the main endoscopic diagnosis (51% of patients). Gastroduodenal (GD) ulcer was significantly more frequent in NSAID users, whereas oesophagitis and bleeding oesophageal varices were more frequent among non-users. Analysis of odds ratio's demonstrated NSAID use to significantly increase the risk for gastric ulcer in the whole patient group (OR = 2.73; 95% confidence interval (CI) : 1.983.77; p < 0.001) and, in addition, for duodenal ulcer in the elderly (>65y) subgroup (OR = 2.91; 95 % CI : 1.52-5.59; p < 0.05). Conclusions : This survey confirms the high incidence of GD ulcers in NSAID users and the risk for serious gastrointestinal complications, often occurring without warning symptoms. It underlines the impact of NSAID use on the routine endoscopy load, the necessity of careful selection of patients for NSAID prescriptions and the need for gastropreventive measures, particularly in elderly patients and patients associating multiple risk factors.
Disciplines :
Gastroenterology & hepatology
Author, co-author :
Belaiche, Jacques ; Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie
Burette, A.
De Vos, M.
Louis, Edouard ; Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie
Huybrechts, M.
Deltenre, M.
Language :
English
Title :
Observational survey of NSAID-related upper gastro-intestinal adverse events in Belgium
Cullen D., Bardhan K.D., Eisner M., Kogut D.G., Peacock R.A., Thomson J.M., Hawkey C.J. (1998) Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users. Aliment Pharmacol. Ther. 12:135-140.
Agrawal N.M., Aziz K. (1998) Prevention of gastrointestinal complications associated with nonsteroidal antiinflammatory drugs. J. Rheumatol. 25(SUPPL. 51):17-20.
Lanza F.L. (1998) A guideline for the treatment and prevention of NSAIDinduced ulcers. Am. J. Gastroenterology 93:2037-2046.
Laine L. (2001) Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenterology 120:594-606.
Agrawal N.M. (1995) Epidemiology and prevention of non-steroidal anti-inflammatory drug effects in the gastrointestinal tract. Br. J. Rheumatol. 34(SUPPL. 1):5-10.
Wolfe M.M., Lichtenstein D.R., Singh G. (1999) Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 340:1888-1899.
Deltenre M., Geboes K., Ectors N., Burette A., Debongnie J.C., Lamy V., Cadranel S., Colemont L., De Koster E., De Prez C., Deprez P., Dumonceau J.L., Glupczunski Y., Melange M., Peeters M., Ramdani B., Scaillon M. (1998) The 1998 national Belgian consensus meeting on HP-related diseases: An extensive summary. Acta Gastroenterol. Belg. 61:299-302.
Rostom A., Wells G., Tugwell P., Welch V., Dube C., McGowan J. (2000) Prevention of chronic NSAID-induced gastrointestinal toxicity: A Cochrane collaboration metaanalysis or randomized controlled trials. J. Rheumatol. 27:2203-2214.
Mc Carthy D. (1998) Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: Definitions and epidemiology. Am. J. Med. 105.
Griffin M.R., Piper J.M., Daugherty J.R., Snowden M., Ray W.A. (1991) Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann. Intern. Med. 114:257-263.
Scarpignato C., Bjarnason I., Bretagne J.F., De PouVourville G., Garcia Rodriguez L.A., Goldstein J.L., Müller P., Simon M.B. (1999) Towards a GI safer antiinflammatory therapy. Gastroenterol. Int. 12:186-215.
Silverstein F.E., Graham D.Y., Senior J.R., Davies H.W., Struthers B.J., Bittman R.M., Geis G.S. (1995) Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, doubleblind, placebo-controlled trial. Ann. Intern. Med. 123:241-249.
Gabriel S.E., Jaakkimainen L., Bombardier C. (1991) Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann. Intern. Med. 115:787-796.
Voutilainen M., Sokka T., Juhola M., Farkkila M., Hannonen P. (1998) Nonsteroidal anti-inflammatory drug-associated upper gastrointestinal lesions in rheumatoid arthritis patients. Relationships to gastric histology, Helicobacter pylori infection, and other risk factors for peptic ulcer. Scand. J. Gastroenterol. 33:811-816.
MacDonald T.M., Morant S.V., Robinson G.C., Shield M.J., McGilchrist M.M., Murray F.E., McDevitt D.G. (1997) Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: Cohort study. BMJ 315:1333-1337.
Perez Gutthann S., Garcia Rodriguez L.A., Raiford D.S. (1997) Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology 8:18-24.
Garcia Rodriguez L.A., Jick H. (1994) Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 343:769-772.
Holvoet J., Terriere L., Van Hee W., Verbist L., Fierens E., Hautekeete M.L. (1991) Relation of upper gastrointestinal bleeding to non-steroidal anti-inflammatory drugs and aspirin: A case-control study. Gut 32:730-374.
Savage R.L., Moller P.W., Ballantyne C.L., Wells J.E. (1993) Variation in the risk of peptic ulcer complications with nonsteroidal anti-inflammatory drug therapy. Arthritis Rheum. 36:84-90.
Singh G., Triadafilopoulos G. (1999) Epidemiology of NSAID induced gastrointestinal complications. J. Rheumatol. 26(SUPPL. 56):18-24.